Cardax, Inc. CDXI

CDXI Company Overview

Cardax, Inc. is a U.S.-based life sciences and consumer health company focused on developing and commercializing astaxanthin-based health and wellness products. The company operates primarily in the nutraceutical and biotechnology sectors, with activities centered on proprietary formulations derived from astaxanthin, a carotenoid antioxidant. Cardax has historically positioned itself at the intersection of consumer wellness, pharmaceutical research, and cardiovascular health science through both dietary supplement commercialization and clinical-stage development efforts.

The company’s principal commercial product line has been ZanthoSyn, a dietary supplement formulated around pharmaceutical-grade astaxanthin technology. Cardax has also pursued pharmaceutical development programs involving its proprietary astaxanthin compounds for inflammatory and cardiovascular applications. The company evolved from a biotechnology research enterprise into a dual-focused organization combining consumer health commercialization with intellectual property development. Public filings and investor materials indicate that Cardax’s strategy has emphasized differentiated science-backed antioxidant formulations and intellectual property protection around astaxanthin delivery and purity.